AMOXICILLIN-CLAVULANIC ACID FOR TREATING DRUG-RESISTANT MYCOBACTERIUM-TUBERCULOSIS

被引:94
作者
NADLER, JP
BERGER, J
NORD, JA
COFSKY, R
SAXENA, M
机构
[1] UNIV S FLORIDA, SCH MED, DEPT MED, TAMPA, FL 33620 USA
[2] DEPT VET AFFAIRS, BAY PINES, FL USA
关键词
D O I
10.1378/chest.99.4.1025
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
This report describes two patients with multidrug resistant tuberculosis who were successfully treated with the addition of amoxicillin-clavulanic acid to second-line drugs. Mycobacterium tuberculosis possesses a beta-lactamase contributing to its resistance to beta-lactam antibiotics. The combination of clavulanic acid, a beta-lactamase inhibitor, and amoxicillin has been shown bactericidal for M tuberculosis in vitro. These data suggest that resistant tuberculosis may warrant a trial of treatment including amoxicillin-clavulanic acid.
引用
收藏
页码:1025 / 1026
页数:2
相关论文
共 8 条
[1]  
Abraham EP, 1941, LANCET, V2, P177
[2]   INVITRO ACTIVITY OF AMOXICILLIN IN COMBINATION WITH CLAVULANIC ACID AGAINST MYCOBACTERIUM-TUBERCULOSIS [J].
CYNAMON, MH ;
PALMER, GS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (03) :429-431
[3]   THE EFFECT OF PENICILLIN ON THE TUBERCLE BACILLUS - TUBERCLE PENICILLINASE [J].
ILAND, CN ;
BAINES, S .
JOURNAL OF PATHOLOGY AND BACTERIOLOGY, 1949, 61 (03) :329-335
[4]  
KASIK JE, 1966, AM REV RESPIR DIS, V94, P260
[5]   NATURE OF MYCOBACTERIAL PENICILLINASE [J].
KASIK, JE .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1965, 91 (01) :117-&
[6]  
KASIK JE, 1967, AM REV RESPIR DIS, V95, P12
[7]  
KASIK JOHN E., 1965, P315
[8]  
SOLTYS M A, 1952, Tubercle, V33, P120, DOI 10.1016/S0041-3879(52)80054-6